Annual Current Liabilities
$13.78 M
+$9.60 M+229.74%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual total current liabilities is $13.78 million, with the most recent change of +$9.60 million (+229.74%) on December 31, 2023.
- During the last 3 years, XLO annual current liabilities has risen by +$11.24 million (+442.26%).
- XLO annual current liabilities is now at all-time high.
Performance
XLO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$38.02 M
-$619.00 K-1.60%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly total current liabilities is $38.02 million, with the most recent change of -$619.00 thousand (-1.60%) on September 30, 2024.
- Over the past year, XLO quarterly current liabilities has increased by +$22.07 million (+138.28%).
- XLO quarterly current liabilities is now -1.60% below its all-time high of $38.64 million, reached on June 30, 2024.
Performance
XLO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
XLO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +229.7% | +138.3% |
| 3 y3 years | +442.3% | +138.3% |
| 5 y5 years | +926.6% | +138.3% |
XLO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +613.7% | -1.6% | +211.0% |
| 5 y | 5-year | at high | +720.6% | -1.6% | +211.0% |
| alltime | all time | at high | +3177.0% | -1.6% | +211.0% |
Xilio Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $38.02 M(-1.6%) |
| Jun 2024 | - | $38.64 M(+22.4%) |
| Mar 2024 | - | $31.58 M(+97.9%) |
| Dec 2023 | $13.78 M(+229.7%) | $15.96 M(-5.7%) |
| Sep 2023 | - | $16.93 M(+3.9%) |
| Jun 2023 | - | $16.29 M(+0.6%) |
| Mar 2023 | - | $16.19 M(-23.3%) |
| Dec 2022 | $4.18 M | $21.12 M(+25.4%) |
| Sep 2022 | - | $16.84 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $17.77 M(+45.4%) |
| Mar 2022 | - | $12.22 M(-4.3%) |
| Dec 2021 | $1.93 M(-24.0%) | $12.78 M(-0.7%) |
| Sep 2021 | - | $12.87 M(-39.6%) |
| Jun 2021 | - | $21.30 M(-3.8%) |
| Dec 2020 | $2.54 M(+51.3%) | $22.16 M |
| Dec 2019 | $1.68 M(+25.1%) | - |
| Dec 2018 | $1.34 M(+219.2%) | - |
| Dec 2017 | $420.50 K(-13.4%) | - |
| Dec 2016 | $485.70 K | - |
FAQ
- What is Xilio Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Xilio Therapeutics?
- What is Xilio Therapeutics annual current liabilities year-on-year change?
- What is Xilio Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly current liabilities year-on-year change?
What is Xilio Therapeutics annual total current liabilities?
The current annual current liabilities of XLO is $13.78 M
What is the all time high annual current liabilities for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total current liabilities is $13.78 M
What is Xilio Therapeutics annual current liabilities year-on-year change?
Over the past year, XLO annual total current liabilities has changed by +$9.60 M (+229.74%)
What is Xilio Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of XLO is $38.02 M
What is the all time high quarterly current liabilities for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total current liabilities is $38.64 M
What is Xilio Therapeutics quarterly current liabilities year-on-year change?
Over the past year, XLO quarterly total current liabilities has changed by +$22.07 M (+138.28%)